Medical and Biological Computing Laboratory, Department of Bio-Sciences, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, India.
J Cell Physiol. 2021 Jan;236(1):468-479. doi: 10.1002/jcp.29874. Epub 2020 Jun 15.
Proteus mirabilis is one among the most frequently identified pathogen in patients with the urinary tract infection. The multidrug resistance exhibited by P. mirabilis renders the treatment ineffective, and new progressive strategies are needed to overcome the antibiotic resistance (AR). We have analyzed the evolutionary relationship of 29 P. mirabilis strains available in the National Center for Biotechnology Information-Genome database. The antimicrobial resistance genes of P. mirabilis along with the enriched pathways and the Gene Ontology terms are analyzed using gene networks to understand the molecular basis of AR. The genes rpoB, tufB, rpsl, fusA, and rpoA could be exploited as potential drug targets as they are involved in regulating the vital functions within the bacterium. The drug targets reported in the present study will aid researchers in developing new strategies to combat multidrug-resistant P. mirabilis.
奇异变形杆菌是尿路感染患者中最常被识别的病原体之一。奇异变形杆菌表现出的多药耐药性使得治疗无效,需要新的渐进策略来克服抗生素耐药性(AR)。我们分析了国家生物技术信息中心-基因组数据库中可用的 29 株奇异变形杆菌的进化关系。使用基因网络分析奇异变形杆菌的抗菌药物耐药基因以及富集的途径和基因本体论术语,以了解 AR 的分子基础。rpoB、tufB、rpsl、fusA 和 rpoA 等基因可作为潜在的药物靶点加以利用,因为它们参与调节细菌的重要功能。本研究报告的药物靶点将有助于研究人员制定新的策略来对抗多药耐药奇异变形杆菌。